Skip to content

Combating Opioid Dependence

Combating Opioid Dependence

The opioid epidemic is a hot topic across the United States, along with the alternatives that could alleviate the tragic consequences the epidemic brings. Opioids, also known as narcotics, are strong prescription pain relievers such as oxycodone, hydrocodone and fentanyl. Although illegal, heroin is also considered to be an opioid. Most patients are introduced to these strong narcotics after a major injury or surgery and should only use them on a short-term basis. Unfortunately, this short-term timeline is not always followed, and the patient can become dependent on the pain killers for everyday life.

Understanding Opioid Dependence

Every day, more than 130 people in the United States die from an opioid overdose – including prescription pain relievers, heroin and synthetics. See below for additional facts we’ve uncovered regarding the opioid crisis:

  • Roughly 21-29% of patients prescribed opioids for chronic pain misuse them
  • Between 8-12% develop an opioid use disorder
  • An estimated 4-6% who misuse prescription opioids transition to heroin
  • About 80% of people who use heroin first misused prescription opioids

Ultimately, the opioid epidemic has become a severe national crisis that affects public health as well as social and economic welfare. Not only does the devastating issue carry consequences like an increase in opioid misuse and related overdoses, it’s also a catalyst for neonatal abstinence syndrome due to opioid use during pregnancy. As more opioid users turn to something stronger, like heroin, an increase in injection drug use follows, contributing to the spread of infectious diseases such as HIV and hepatitis C.

A Better Option

Both prescription opioids and cannabis have the same primary use: analgesia – the inability to feel pain. Currently, up to 90% of patients in state-level medical cannabis registries list chronic pain as their qualifying condition. According to a review conducted by the National Academies of Science and Medicine, when given access to cannabis, patients currently using opioids for chronic pain decreased their use by 40-60% and reported that they prefer cannabis rather than opioids. Patients also reported fewer side effects with cannabis and a better quality of life compared to opioids. 

Although there is minimal clinical literature that supports the use of cannabis as a treatment for acute pain, there is a long-standing body of pre-clinical evidence that demonstrates the effectiveness of cannabinoids in providing a pain-free life in drug-naïve animals.

“The mechanisms of cannabinoid antinociception are remarkably similar to those of opioid analgesics. Both the CB1 and MOR are G-protein coupled receptors, and agonist-initiated disinhibition of GABA release in the descending pain pathway is just one example of overlapping antinociceptive mechanisms between these drugs.” -NCBI.gov

The evidence we do have that supports the role of cannabis in acute, nonsevere pain management could lead to a substantial reduction in opioid prescription use. This increase in medical marijuana use for treating acute pain could eliminate patients being exposed to the risks of opioid dose escalation and physical dependence. We still have a long way to go, but the potential impact of this therapy definitely warrants further exploration of the efficacy of cannabis for pain relief and eliminating opioid dependence.

Interested in learning more about medical cannabis efficacies for opioid dependence or other qualifying conditions? Join Arfinn Med for FREE today to access HIPAA compliant peer-to-peer data on medical marijuana treatment efficacies, discuss treatment plans with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources: https://medlineplus.gov/healthtopics/opioidabuseandaddiction_b.html?utm_expid=.YDctbaKlRwemM6rjn-4YCA.2&utm_referrer=https%3A%2F%2Fwww.google.com%2F

https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135562/

Stories you may be interested in

Thanks to the Farm Bill, Hemp Is Legal. Here’s What It Means for CBD.

On Tuesday, the Senate voted to approve a new an $867 billion farm bill, and on Wednesday, it passed in Congress. While the bill has plenty of positive merits, the one people are perhaps most excited about is the fact that it will legalize the production, sale, and distribution of industrial hemp at a federal…
Read More

DeSantis OKs telehealth for Florida medical marijuana patients

TAMPA, Fla. (WFLA) — Florida Gov. Ron DeSantis signed a bill allowing the state’s 828,000 medical marijuana patients to use telehealth to visit their doctors. On Monday, DeSantis signed HB-387, titled “Medical Use of Marijuana,” which allows patients renewing their medical marijuana recommendation to meet with their doctors online. Currently, patients must visit their doctor in person…
Read More

Medical Marijuana a Hit With Seniors

In a new survey, those who turned to it for treating chronic pain reported it reduced pain and decreased the need for opioid painkillers. Nine out of 10 liked it so much they said they’d recommend medical pot to others. “I was on Percocet and replaced it with medical marijuana. Thank you, thank you, thank you,” said one senior. Another patient put…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page…
Read More

Leave a Comment

You must be logged in to post a comment.